Panel to FDA: Give OK to Vertex hepatitis C drug
Boston, Robert Weisman, April 28th, 2011- A medical advisory committee today unanimously recommended that the US Food and Drug Administration approve a hepatitis C drug developed by Cambridge-based Vertex Pharmaceuticals Inc. — which could become the first new blockbuster drug developed by a Massachusetts company in seven years.
The FDA’s decision on the Vertex drug, called telaprevir, is expected next month.
After a day of testimony in which executives, regulators, doctors, and patients spoke of telaprevir’s effectiveness but also warned of side effects such as rashes and anemia, the antiviral drugs advisory committee voted 18 to 0 to recommend approval.
Short URL: http://www.worldhealthconnection.com/?p=3601